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We have read with curiosity the systematic review 
of aluminium phosphide poisoning by Mehrpour et al. 
(1) recently published in the Archives of Industrial 
Hygiene and Toxicology. They mentioned potassium 
permanganate (1:10,000 solution) as an option in the 
management of aluminium phosphide toxicity and 
claimed that it can oxidise phosphine gas in the stomach 
to phosphate, and therefore decrease the quantity of 
lethal phosphine gas. Here the authors cite two case 
reports using potassium permanganate (1:10,000 
solution) without any strong scientiﬁ c basis (2, 3).
As we know, in contact with mucus potassium 
permanganate (KMnO4) forms manganese dioxide, 
potassium hydroxide, and free oxygen radical. 
Therefore it can lead to systemic toxicity itself (4). 
Because of its weak bonds with the aluminium-based 
compound, phosphine gas (PH3) can easily be released 
after ingestion (5). PH3 is a hard nucleophile (species 
with increased electron density over a small area) and 
therefore tends to react with hard electrophiles (4, 6), 
but phosphine, the small nucleophile, and free oxygen 
radical, another small nucleophile, do not interact with 
each other.
The only clinical indication for potassium 
permanganate prescription may be white phosphorus 
(P4) ingestion, as it converts it to a less destructive 
oxide compound. However, due to its chemical 
properties, clinicians should be aware of the risk of 
systemic toxicity. In addition, no clinical trials have 
yet determined its risk-to-beneﬁ t proﬁ le (4).
We think that prescribing potassium permanganate 
in aluminium phosphide poisoning stems from an 
ancient misperception of the chemical structure of 
phosphine (PH3) versus white phosphorus (P4).
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